Skip to main content
. 2019 Nov 21;14(11):e0225575. doi: 10.1371/journal.pone.0225575

Fig 2. Prevalence of nucleoside reverse transcriptase inhibitor (NRTI) and non-nucleoside reverse transcriptase inhibitor (NNRTI) mutations.

Fig 2